ORIGINAL RESEARCH
Published on 18 Nov 2021
The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
doi 10.3389/fimmu.2021.748103
- 8,455 views
- 27 citations
- Frontiers in Immunology
- Vaccines and Molecular Therapeutics
- Research Topics
- Immunomodulation: the New Horizon for the Treatment of Viral Infections
Immunomodulation: the New Horizon for the Treatment of Viral Infections
16k
Total downloads
63k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 01 Nov 2021
Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators
doi 10.3389/fimmu.2021.768695
- 5,498 views
- 12 citations
REVIEW
Published on 01 Oct 2021
Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics
doi 10.3389/fimmu.2021.752227
- 7,982 views
- 25 citations
ORIGINAL RESEARCH
Published on 24 Aug 2021
A Novel Bifunctional Fusion Protein, Vunakizumab-IL22, for Protection Against Pulmonary Immune Injury Caused by Influenza Virus
doi 10.3389/fimmu.2021.727941
- 3,065 views
- 7 citations
REVIEW
Published on 30 Jun 2021
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
doi 10.3389/fimmu.2021.658519
- 25,486 views
- 72 citations
MINI REVIEW
Published on 28 May 2021
Prospects of Neutralizing Nanobodies Against SARS-CoV-2
doi 10.3389/fimmu.2021.690742
- 5,093 views
- 35 citations
Published in
Frontiers in Immunology
- Vaccines and Molecular Therapeutics
Impact
- 63kTopic views
- 46kArticle views
- 16kArticle downloads